The ability to predict the fate of patients after the removal of a neoplasm has remained a perpetual goal for pathologists. To accomplish this, the modem pathologist not only seeks to distinguish between benign and malignant tumours, but also to anticipate which of those frankly malignant neoplasms will pose the greatest threat to survival. To Gross structural abnormalities of the nucleus reflect, at least in part, aberrations of the cell karyotype. The normal human somatic cell contains 46 chromosomes (23 pairs) and is referred to as diploid. A cell with fewer or more than 46 chromosomes is described as aneuploid. Karyotypic abnormalities are a well recognised feature of human cancers. The loss or gain of a chromosome may alter the amount of specific cell products and, if these are crucial in controlling cell division and differentiation, may lead to unrestrained proliferation. Furthermore, genetic abnormalities may lead to increasing karyotypic instability and a higher rate of spontaneous mutation which, in turn, will permit the more rapid progression to a highly malignant phenotype. 1 12 Recently, investigators have analysed the karyotypes of uveal melanomas and found non-random chromosome abnormalities. [13] [14] [15] While karyotypic analysis may provide us with clues as to the initiating events in the development of neoplasms, it is extremely time consuming and requires fresh tumour tissue; for these reasons it is unlikely that it could be used routinely as a method of assessing prognosis. In contrast, flow cytometry is an automated method of quantifying the cellular DNA content of a tumour. In essence, a suspension of tumour cells is obtained and stained with fluorescent dye which will bind directly to DNA. This labelling is stoichiometric -that is, the degree of staining is directly proportional to the amount of DNA present. The suspension is then passed through a flow cytometer which can rapidly measure the amount of fluorescence, and hence the amount of DNA in an individual cell. The analysis of several thousand cells provides information about the ploidy and rate of cellular proliferation of the tumour. Studies in other human tumours using this 
